Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 47335-410

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 47335-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sumatriptan-and-naproxen-figure1 (Spl Sumatriptan And Naproxen Figure1)

The figure shows the percentage of adult patients who experienced initial headache pain relief within two hours after taking Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg, Sumatriptan 85 mg with Naproxen Sodium 500 mg, and placebo. The graph also shows the time postdose.*

FDA Label Image

Spl-sumatriptan-and-naproxen-figure2 (Spl Sumatriptan And Naproxen Figure2)

FDA Label Image

Spl-sumatriptan-and-naproxen-label (Spl Sumatriptan And Naproxen Label)

This is a medication label for Sumatriptan and Naproxen Sodium Tablets, with a strength of 85 mg/500 mg. The pharmacist is instructed to dispense the medication with a separate Medication Guide for each patient. There are a total of 9 tablets in the container. The NDC number for this medication is 47335-410-22. The label also includes a product code, PGLBO767, and a date, 08/2016.*

FDA Label Image

Spl-sumatriptan-and-naproxen-naproxen-sodium-str (Spl Sumatriptan And Naproxen Naproxen Sodium Str)

FDA Label Image

Spl-sumatriptan-and-naproxen-sumatriptan-str (Spl Sumatriptan And Naproxen Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.